ADARx Pharmaceuticals IPO

ADARx Pharmaceuticals is a company that specializes in genetic medicine designed to treat human diseases and ailments using mRNA transcripts. ADARx researches and develops its therapies through oligonucleotides delivery technology. The firm focuses on three main disease treatments: genetic diseases, cardiometabolic diseases, and central nervous system (CNS) diseases.

Register for Details

For more details on financing and valuation for ADARx Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about ADARx Pharmaceuticals

Forge green plus iconForge green minus icon

What is ADARx Pharmaceuticals's IPO price?

The IPO price for ADARx Pharmaceuticals will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in ADARx Pharmaceuticals?

ADARx Pharmaceuticals is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell ADARx Pharmaceuticals shares pre-IPO?

If you own ADARx Pharmaceuticals pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is ADARx Pharmaceuticals a publicly traded company?

ADARx Pharmaceuticals is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is ADARx Pharmaceuticals's funding to date?

ADARx Pharmaceuticals has raised $352.5MM to date.
Forge green plus iconForge green minus icon

When was ADARx Pharmaceuticals founded?

ADARx Pharmaceuticals was founded in 2019.

Who are ADARx Pharmaceuticals's major investors?

T. Rowe Price
Vivo Capital
Ascenta Capital
Sirona Capital
Lilly Asia Ventures
SR One
TCG Crossover Management
Bain Capital Life Sciences

ADARx Pharmaceuticals Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
8/9/2023 Series C $200MM raised $XXX.XX $XXX.XX
1/20/2023 Series B-1 $46MM raised $XXX.XX $XXX.XX
9/8/2021 Series B $75MM raised $XXX.XX $XXX.XX
5/14/2021 Series A $31.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.